Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality
Saeed A, Björkander E, Carlström J, Guron G, Kashioulis P, Kindblom JM, Lönnbro Widgren J, Svanberg T, Strandell A
Record ID 32016000596
English
Authors' recommendations:
There is no data demonstrating that twice-weekly HD compromises HRQL or is associated with an increased risk of mortality or cardiovascular events in selected patients with residual kidney function, compared with thrice-weekly HD. The quality of evidence was very low for all studied outcomes (GRADE +000). Randomised controlled studies or observational studies of high quality are needed.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://www2.sahlgrenska.se/upload/SU/HTA-centrum/HTA-rapporter/HTA-report%20Hemodialysis%20twice%20versus%20three%20times%20a%20week%20%20incl%20app%202015-02-05_ASit.pdf
URL for additional information:
http://www.sahlgrenska.se/sv/SU/Forskning/HTA-centrum/Hogerkolumn-undersidor/Publicerade-rapporter/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
MeSH Terms
- Humans
- Cardiovascular System
- Kidney Failure, Chronic
- Quality of Life
- Renal Dialysis
Contact
Organisation Name:
The Regional Health Technology Assessment Centre
Contact Address:
The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden
Contact Name:
hta-centrum@vgregion.se
Contact Email:
hta-centrum@vgregion.se
Copyright:
The Regional Health Technology Assessment Centre (HTA-centrum), Region Vastra Gotaland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.